Tag: Precision oncology for GI cancers

Home / Precision oncology for GI cancers

Categories

Pembrolizumab with chemotherapy is approved by the USFDA for biliary tract cancer

On October 31, 2023, the Food and Drug Administration approved pembrolizumab (Keytruda, Merck) to be used with gemcitabine and cisplatin to treat biliary tract carcinoma (BTC) that has spread or is l...
precision-oncology-for-gi-cancers

Scan the code